Nancy Miller-Rich - Jun 10, 2025 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Nancy Miller-Rich
Stock symbol
ALDX
Transactions as of
Jun 10, 2025
Transactions value $
$0
Form type
4
Date filed
6/12/2025, 04:30 PM
Previous filing
Jun 6, 2024
Next filing
Jun 20, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Miller-Rich Nancy Director C/O ALDEYRA THERAPEUTICS, INC., 131 HARTWELL AVENUE, LEXINGTON /s/ Nancy Miller-Rich 2025-06-12 0001735084

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Award $0 +62.7K $0.00 62.7K Jun 10, 2025 Common Stock 62.7K $2.69 Direct F1
transaction ALDX Stock Option (Right to Buy) Award $0 +2.41K $0.00 2.41K Jun 10, 2025 Common Stock 2.41K $2.69 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
F2 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date.